Gilead Sciences
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell GILD and other ETFs, options, and stocks.About GILD
Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases.
GILD Key Statistics
GILD News
For Immediate Release Chicago, IL – May 3, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research anal...
Key Insights Gilead Sciences' Annual General Meeting to take place on 8th of May Total pay for CEO Dan O'Day includes US$1.74m salary The total compensation...
FOSTER CITY, Calif., April 30, 2024--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following...
Analyst ratings
55%
of 33 ratingsMore GILD News
Gilead Sciences, Inc. (NASDAQ:GILD) Q1 2024 Earnings Call Transcript April 25, 2024 Gilead Sciences, Inc. beats earnings expectations. Reported EPS is $-1.32,...
Gilead Sciences (GILD) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that cou...
Gilead Sciences has received a US Food and Drug Administration (FDA) approval for the label expansion of its human immunodeficiency virus -1 (HIV-1) fixed combi...
Gilead Sciences (NASDAQ:GILD) First Quarter 2024 Results Key Financial Results Revenue: US$6.69b (up 5.3% from 1Q 2023). Net loss: US$4.17b (down from US$1.0...
